Toxoplasma gondii infection in the United States: seroprevalence and risk factors.
about
Comparative genomics of the apicomplexan parasites Toxoplasma gondii and Neospora caninum: Coccidia differing in host range and transmission strategyToxoplasmosis--a global threat. Correlation of latent toxoplasmosis with specific disease burden in a set of 88 countriesIncreased incidence of traffic accidents in Toxoplasma-infected military drivers and protective effect RhD molecule revealed by a large-scale prospective cohort studyDescribing the relationship between cat bites and human depression using data from an electronic health recordNeglected parasitic infections in the United States: toxoplasmosisManagement of toxoplasmic encephalitis in HIV-infected adults (with an emphasis on resource-poor settings)Management of toxoplasmic encephalitis in HIV-infected adults (with an emphasis on resource-poor settings)Is Toxoplasma Gondii Infection Related to Brain and Behavior Impairments in Humans? Evidence from a Population-Representative Birth Cohort.Transmission and epidemiology of zoonotic protozoal diseases of companion animalsCorrelates of serum lipoprotein (A) in children and adolescents in the United States. The third National Health Nutrition and Examination Survey (NHANES-III)Seroprevalence and risk factors for toxoplasma infection among pregnant women in Aydin province, Turkey.Molecules to modeling: Toxoplasma gondii oocysts at the human-animal-environment interfaceToxoplasma gondii calcium-dependent protein kinase 1 is a target for selective kinase inhibitorsInhibition and Structure of Toxoplasma gondii Purine Nucleoside PhosphorylaseDetermining UV inactivation of Toxoplasma gondii oocysts by using cell culture and a mouse bioassayComputational analysis and experimental validation of gene predictions in Toxoplasma gondiiSeroprevalence of Toxoplasma gondii in domestic pets from metropolitan regions of PanamaGlobalization and the population structure of Toxoplasma gondiiDrinking water source and human Toxoplasma gondii infection in the United States: a cross-sectional analysis of NHANES data.Proteomic analysis of cleavage events reveals a dynamic two-step mechanism for proteolysis of a key parasite adhesive complex.Genetic diversity of Toxoplasma gondii in animals and humans.Longer pregnancy and slower fetal development in women with latent "asymptomatic" toxoplasmosisThe evolutionary puzzle of suicide.EPIC-DB: a proteomics database for studying Apicomplexan organismsSero-prevalence of latent Toxoplasma gondii infection among HIV-infected and HIV-uninfected people in Addis Ababa, Ethiopia: A comparative cross-sectional study.Seroepidemiology of human Toxoplasma gondii infection in China.Immunoprevalence to Six Waterborne Pathogens in Beachgoers at Boquerón Beach, Puerto Rico: Application of a Microsphere-Based Salivary Antibody Multiplex Immunoassay.Diclazuril Protects against Maternal Gastrointestinal Syndrome and Congenital Toxoplasmosis.The role of DNA microarrays in Toxoplasma gondii research, the causative agent of ocular toxoplasmosis.Guidelines for the Prevention and Treatment of Opportunistic Infections among HIV-exposed and HIV-infected children: recommendations from CDC, the National Institutes of Health, the HIV Medicine Association of the Infectious Diseases Society of AmerSeroepidemiological study of Toxoplasma gondii infection in a population of Iranian epileptic patients.Annual burden of ocular toxoplasmosis in the US.Toxoplasma gondii seroprevalence in the United States 2009-2010 and comparison with the past two decades.Seroprevalence and Risk Factors of Toxoplasma gondii Infection among Cat Sitters in Korea.Toxoplasma gondii seropositivity and co-infection with TORCH pathogens in high-risk patients from Qatar.Varicella seroprevalence in the U.S.: data from the National Health and Nutrition Examination Survey, 1999-2004.Localized multigene expression patterns support an evolving Th1/Th2-like paradigm in response to infections with Toxoplasma gondii and Ascaris suum.Toxoplasma Gondii Moderates the Association between Multiple Folate-Cycle Factors and Cognitive Function in U.S. Adults.A prospective analysis of the Ab response to Plasmodium falciparum before and after a malaria season by protein microarrayThe association of Toxoplasma gondii infection with neurocognitive deficits in a population-based analysis.
P2860
Q21090491-95594C71-00EB-4A77-B18D-41F9A38ADF13Q21090649-F5479681-B143-4D6D-B7E1-1899992D9747Q21261521-0C47C074-BD4A-46F1-B0EF-665A43AB86DBQ21559577-CA0F05C8-7E7C-44F9-9959-CC85748A0B28Q22305416-83061112-A187-4FA2-A86E-1E1D5A666818Q24245334-3E259BA1-CA16-4A7A-BD70-101D37EFF06CQ24246778-0AF6EAFD-D6FC-473D-ACEF-5AF480365558Q24288638-4DC5BE67-3959-4004-A186-D07895AB0740Q24630763-8C0D64F0-E162-423C-9703-71DFEE68116AQ24804113-E4C742E2-383B-480C-B8B1-3F62E8308CBEQ24813476-75A220A4-5975-48E6-9E01-28E2001DBDA0Q26863427-5E9F7A52-BBF0-4781-92F7-68FC7AD2828AQ27661190-3191B748-2AD2-4DFB-9F66-B904CFCF34DDQ27681944-C099C55E-435A-47D3-AD2A-FF90680149D8Q28397529-D4CB92AC-8314-4095-BD05-E0D54C256759Q28474195-EC1A9982-349A-420D-BD3C-D20C5D48E6DFQ28954277-B58B1A66-7213-4D48-8782-0F0F54A2FF3FQ30355588-070F1264-72AC-489D-8FD0-0969527F6416Q30835971-A3710345-5FF2-4204-BB97-909A274F76BAQ31050217-DC4AF0C1-1649-4A79-B599-54B055EB08C5Q31080457-03340D95-97B9-4AE7-A0A7-319329F90DD2Q33301587-0AA4B0C6-372C-4373-992A-0A59DE4BD02EQ33357391-25EAD2AE-AF43-4798-9119-AADE89F1E714Q33401691-BC14EBD0-4E7B-4583-9BA1-F8B77EFEC7F0Q33512112-442BC88B-FC27-44FE-A675-CD0E38CDCA76Q33522475-0630EF9F-6F21-49C8-91E8-857B879DFA1BQ33619565-046711EC-DE6C-480A-B4C3-825543ED4873Q33630974-4BE0DA4D-F6FD-4380-950E-41D1144F0553Q33631447-8670BF2E-5E55-4988-966F-4E800539C428Q33650105-15BB46A0-7DA6-4C34-9E12-8AC81A12C327Q33667202-5018A477-B87C-4D5E-BE4A-B7BDBAC13DB4Q33693661-20A55F57-BA2F-4AD4-9F12-D015C1915734Q33719625-7D620A7F-9C59-42F2-B99C-BF688DC556BFQ33745577-41CDD127-CDCB-4769-A446-87F20B895AB1Q33749597-942D69EE-30B0-4B86-8D8D-2D4210DA4AB0Q33759666-C01AA494-05EB-4D58-A496-98DFC17A598BQ33792618-B27B77BB-40A6-4646-8643-E4BD15A2BEB3Q33851885-CEF9C996-E4DE-49E6-859D-38EFACC697ACQ33859633-2A7FFA4B-D24A-475D-89C7-22F7E9B4D2A2Q33881877-DF2A4461-509C-4197-B8DD-36066A07DC36
P2860
Toxoplasma gondii infection in the United States: seroprevalence and risk factors.
description
2001 nî lūn-bûn
@nan
2001 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Toxoplasma gondii infection in the United States: seroprevalence and risk factors.
@ast
Toxoplasma gondii infection in the United States: seroprevalence and risk factors.
@en
Toxoplasma gondii infection in the United States: seroprevalence and risk factors.
@nl
type
label
Toxoplasma gondii infection in the United States: seroprevalence and risk factors.
@ast
Toxoplasma gondii infection in the United States: seroprevalence and risk factors.
@en
Toxoplasma gondii infection in the United States: seroprevalence and risk factors.
@nl
prefLabel
Toxoplasma gondii infection in the United States: seroprevalence and risk factors.
@ast
Toxoplasma gondii infection in the United States: seroprevalence and risk factors.
@en
Toxoplasma gondii infection in the United States: seroprevalence and risk factors.
@nl
P2093
P356
P1476
Toxoplasma gondii infection in the United States: seroprevalence and risk factors.
@en
P2093
Kruszon-Moran D
McAuley JB
McQuillan G
P304
P356
10.1093/AJE/154.4.357
P407
P577
2001-08-01T00:00:00Z